Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
Open Access
- 8 May 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 5 (5), e1214
- https://doi.org/10.1038/cddis.2014.178
Abstract
Mammalian target of rapamycin (mTOR) is involved in insulin resistance (IR) and diabetic retinopathy. In retinal pigment epithelial (RPE) cells, insulin activates the mTOR pathway, inducing hypoxia-inducible factor-1α (HIF-1α) and HIF-dependent transcription in serum-free minimum essential medium Eagle (MEM). Serendipitously, we found that insulin failed to induce the HIF-1α-dependent response, when RPE cells were cultured in Dulbecco’s modification of Eagle’s medium (DMEM). Whereas concentration of glucose in MEM corresponds to normal glucose levels in blood (5.5 mM), its concentration in DMEM corresponds to severe diabetic hyperglycemia (25 mM). Addition of glucose to MEM also caused IR. Glucose-mediated IR was characterized by basal activation of mTORC1 and its poor inducibility by insulin. Basal levels of phosphorylated S6 kinase (S6K), S6 and insulin receptor substrate 1 (IRS1) S635/639 were high, whereas their inducibilities were decreased. Insulin-induced Akt phosphorylation was decreased and restored by rapamycin and an inhibitor of S6K. IR was associated with de-phosphorylation of IRS1 at S1011, which was reversed by rapamycin. Both short (16–40 h) and chronic (2 weeks) treatment with rapamycin reversed IR. Furthermore, rapamycin did not impair Akt activation in RPE cells cultured in normoglycemic media. In contrast, Torin 1 blocked Akt activation by insulin. We conclude that by activating mTOR/S6K glucose causes feedback IR, preventable by rapamycin. Rapamycin does not cause IR in RPE cells regardless of the duration of treatment. We confirmed that rapamycin also did not impair phosphorylation of Akt at T308 and S473 in normal myoblast C2C12 cells. Our work provides insights in glucose-induced IR and suggests therapeutic approaches to treat patients with IR and severe hyperglycemia and to prevent diabetic complications such as retinopathy. Also our results prompt to reconsider physiological relevance of numerous data and paradigms on IR given that most cell lines are cultured with grossly super-physiological levels of glucose.Keywords
This publication has 68 references indexed in Scilit:
- Phosphorylation of IRS1 at Serine 307 in Response to Insulin in Human Adipocytes Is Not Likely to be Catalyzed by p70 Ribosomal S6 KinasePLOS ONE, 2013
- Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat dietCell Death & Disease, 2013
- Hypoxia suppresses conversion from proliferative arrest to cellular senescenceProceedings of the National Academy of Sciences, 2012
- Targeting adipose tissue angiogenesis to enhance insulin sensitivityDiabetologia, 2012
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and StressMolecular Cell, 2010
- Paradoxical suppression of cellular senescence by p53Proceedings of the National Academy of Sciences, 2010
- Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylationCurrent Opinion in Pharmacology, 2009
- S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2Journal of Biological Chemistry, 2008
- Enhanced activation of a “nutrient‐sensing” pathway with age contributes to insulin resistanceThe FASEB Journal, 2008
- Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?Oncogene, 2006